Back
EyePoint Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
63
EYPT
EyePoint Pharmaceuticals
Last Price:
8.92
Seasonality Move:
-10.5%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.51 | Buy |
| 20-day SMA: | 8.62 | Buy |
| 50-day SMA: | 8.89 | Sell |
| 200-day SMA: | 16.4 | Sell |
| 8-day EMA: | 8.66 | Buy |
| 20-day EMA: | 8.6 | Buy |
| 50-day EMA: | 9.08 | Sell |
| 200-day EMA: | 12.42 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 51.75 | Buy |
| Chaikin Money Flow: | -282377 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.97 - 8.99) | Buy |
| Bollinger Bands (100): | (7.51 - 12.59) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.78 while EYPT 8-day simple moving average is 8.51, which is a Buy signal.
- The stock price of EYPT is 8.78 while EyePoint Pharmaceuticals 20-day SMA is 8.62, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day simple moving average is 8.89 while EYPT share price is 8.78, making it a Sell technically.
- EYPT stock price is 8.78 and EyePoint Pharmaceuticals 200-day simple moving average is 16.40, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Buy
63
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a Buy
The current EyePoint Pharmaceuticals [EYPT] share price is $8.78. The Score for EYPT is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
469.89M
Price in USD:
8.78
Share Volume:
456.15K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
5.67
Buy
63
EyePoint Pharmaceuticals (EYPT)
is a Buy
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?
The EyePoint Pharmaceuticals stock price is 8.78 USD today. -
Will EYPT stock go up or go down?
EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is EyePoint Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is not overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
- EyePoint Pharmaceuticals share price is 8.78 while EYPT 8-day exponential moving average is 8.66, which is a Buy signal.
- The stock price of EYPT is 8.78 while EyePoint Pharmaceuticals 20-day EMA is 8.60, which makes it a Buy.
- EyePoint Pharmaceuticals 50-day exponential moving average is 9.08 while EYPT share price is 8.78, making it a Sell technically.
- EYPT stock price is 8.78 and EyePoint Pharmaceuticals 200-day simple moving average is 12.42, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
- EYPT Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting EyePoint Pharmaceuticals is a Sell
- EyePoint Pharmaceuticals Relative Strength Index (RSI) is 51.75, which suggest EyePoint Pharmaceuticals is overbought
- The Bollinger Bands (25) for EyePoint Pharmaceuticals is (7.97 - 8.99), which suggest EyePoint Pharmaceuticals is a Sell
- The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.51 - 12.59), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.